Merit Melin

1.4k total citations
27 papers, 663 citations indexed

About

Merit Melin is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Merit Melin has authored 27 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Epidemiology and 9 papers in Microbiology. Recurrent topics in Merit Melin's work include SARS-CoV-2 and COVID-19 Research (11 papers), Pneumonia and Respiratory Infections (10 papers) and Bacterial Infections and Vaccines (9 papers). Merit Melin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), Pneumonia and Respiratory Infections (10 papers) and Bacterial Infections and Vaccines (9 papers). Merit Melin collaborates with scholars based in Finland, United States and Sweden. Merit Melin's co-authors include Helena Käyhty, Merja Väkeväinen, Seppo Meri, Outi Vaarala, Bo Lönnerdal, Magnus Domellöf, Olle Hernell, Niklas Timby, Krzysztof Trzciński and Hanna Jarva and has published in prestigious journals such as PLoS ONE, Biochemical Journal and The Journal of Infectious Diseases.

In The Last Decade

Merit Melin

27 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merit Melin Finland 14 348 180 176 126 78 27 663
Dace Zavadska Latvia 15 194 0.6× 305 1.7× 55 0.3× 107 0.8× 210 2.7× 44 645
Abdou Amza United States 15 173 0.5× 97 0.5× 172 1.0× 107 0.8× 125 1.6× 50 532
Juan Pablo Yarzábal Belgium 12 191 0.5× 169 0.9× 90 0.5× 12 0.1× 19 0.2× 22 450
J. J. Roord Netherlands 15 327 0.9× 100 0.6× 286 1.6× 15 0.1× 75 1.0× 27 649
Kevin C. Hong United States 14 289 0.8× 62 0.3× 352 2.0× 34 0.3× 108 1.4× 16 644
Judy Wolf United States 7 508 1.5× 51 0.3× 235 1.3× 57 0.5× 71 0.9× 8 690
Silvia González Ayala Argentina 10 236 0.7× 127 0.7× 223 1.3× 8 0.1× 78 1.0× 15 419
Lance E. Keller United States 12 304 0.9× 44 0.2× 160 0.9× 13 0.1× 106 1.4× 19 483
Gordean Bjornson Canada 10 168 0.5× 116 0.6× 69 0.4× 33 0.3× 45 0.6× 17 340
S. Pinchinat France 12 300 0.9× 90 0.5× 32 0.2× 35 0.3× 27 0.3× 16 496

Countries citing papers authored by Merit Melin

Since Specialization
Citations

This map shows the geographic impact of Merit Melin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merit Melin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merit Melin more than expected).

Fields of papers citing papers by Merit Melin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merit Melin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merit Melin. The network helps show where Merit Melin may publish in the future.

Co-authorship network of co-authors of Merit Melin

This figure shows the co-authorship network connecting the top 25 collaborators of Merit Melin. A scholar is included among the top collaborators of Merit Melin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merit Melin. Merit Melin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uggla, Bertil, Camilla Virta, Merit Melin, et al.. (2025). Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemia. Haematologica. 110(8). 1774–1785. 1 indexed citations
2.
Ekström, Nina, Toni Lehtonen, Anu Haveri, et al.. (2024). Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19. Vaccines. 12(3). 247–247. 5 indexed citations
3.
Ekström, Nina, et al.. (2023). Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022. Emerging Microbes & Infections. 12(2). 2222849–2222849. 13 indexed citations
4.
Auranen, Kari, Sangita Kulathinal, Tommi Härkänen, et al.. (2023). Underreporting of SARS-CoV-2 infections during the first wave of the 2020 COVID-19 epidemic in Finland—Bayesian inference based on a series of serological surveys. PLoS ONE. 18(6). e0282094–e0282094. 2 indexed citations
5.
Jalkanen, Pinja, et al.. (2023). T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency – a 22-month follow-up. Frontiers in Immunology. 14. 1146500–1146500. 5 indexed citations
6.
Ekström, Nina, Camilla Virta, Pamela Österlund, et al.. (2022). Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection. Open Forum Infectious Diseases. 9(12). ofac625–ofac625. 4 indexed citations
7.
Krzyżewska, Eva, Anu Haveri, C Hammer, et al.. (2022). Impaired immunity and high attack rates caused by SARS‐CoV‐2 variants among vaccinated long‐term care facility residents. Immunity Inflammation and Disease. 10(9). e679–e679. 3 indexed citations
8.
Jalkanen, Pinja, Merit Melin, Johanna Teräsjärvi, et al.. (2022). Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients. Frontiers in Immunology. 13. 869990–869990. 33 indexed citations
9.
Ekström, Nina, et al.. (2022). Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects. European Journal of Immunology. 52(5). 816–824. 24 indexed citations
10.
Dub, Timothée, Hanna Nohynek, Camilla Virta, et al.. (2022). High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020–2021. Frontiers in Medicine. 9. 876532–876532. 8 indexed citations
11.
Dub, Timothée, Merit Melin, Anu Haveri, et al.. (2021). COVID-19 outbreak at a reception centre for asylum seekers in Espoo, Finland. Journal of Migration and Health. 3. 100043–100043. 6 indexed citations
12.
Dub, Timothée, Hanna Nohynek, Camilla Virta, et al.. (2021). High Secondary Attack Rate and Persistence of SARS-CoV-2 Antibodies in Household Transmission Study Participants, Finland 2020. SSRN Electronic Journal. 1 indexed citations
13.
Haveri, Anu, Nina Ekström, Camilla Virta, et al.. (2021). Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans. European Journal of Immunology. 51(12). 3202–3213. 60 indexed citations
14.
Kontio, Mia, Arto A. Palmu, Ritva Syrjänen, et al.. (2016). Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months. The Journal of Infectious Diseases. 213(12). 2005–2013. 10 indexed citations
15.
Einarsdóttir, Elísabet, Erna Kentala, Sari Hammarén‐Malmi, et al.. (2015). Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) Locus. PLoS ONE. 10(7). e0132551–e0132551. 28 indexed citations
16.
Hermand, Philippe, et al.. (2014). Role of Pht Proteins in Attachment of Streptococcus pneumoniae to Respiratory Epithelial Cells. Infection and Immunity. 82(4). 1683–1691. 39 indexed citations
17.
Timby, Niklas, Olle Hernell, Outi Vaarala, et al.. (2014). Infections in Infants Fed Formula Supplemented With Bovine Milk Fat Globule Membranes. Journal of Pediatric Gastroenterology and Nutrition. 60(3). 384–389. 141 indexed citations
18.
Melin, Merit, et al.. (2012). Development of cross-reactive antibodies to the proline-rich region of pneumococcal surface protein A in children. Vaccine. 30(50). 7157–7160. 13 indexed citations
19.
Melin, Merit, Susan K. Hollingshead, David E. Briles, et al.. (2008). Development of Antibodies to PspA Families 1 and 2 in Children after Exposure to Streptococcus pneumoniae. Clinical and Vaccine Immunology. 15(10). 1529–1535. 21 indexed citations
20.
Simell, Birgit, Merit Melin, Mika Lahdenkari, et al.. (2007). Antibodies to Pneumococcal Surface Protein A Families 1 and 2 in Serum and Saliva of Children and the Risk of Pneumococcal Acute Otitis Media. The Journal of Infectious Diseases. 196(10). 1528–1536. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dace Zavadska Breakdown of academic impact, for papers by Abdou Amza Breakdown of academic impact, for papers by Juan Pablo Yarzábal Breakdown of academic impact, for papers by J. J. Roord Breakdown of academic impact, for papers by Kevin C. Hong Breakdown of academic impact, for papers by Judy Wolf Breakdown of academic impact, for papers by Silvia González Ayala Breakdown of academic impact, for papers by Lance E. Keller Breakdown of academic impact, for papers by Gordean Bjornson Breakdown of academic impact, for papers by S. Pinchinat
Rankless by CCL
2026